SUOMEN TERVEYSTALO OYJ      INTERIM REPORT
May 15, 2008 at 1 p.m.                                                          


Terveystalo's January-March 2008 turnover increased by 80.7 percent and was EUR
52.9 million, while operating profit was EUR 4.4 million 

January-March 2008 (January-March 2007):                                        
- Turnover EUR 52.9 million (29.3) 
- Operating profit EUR 4.4 million (2.6) 
-- Turnover for the Occupational Healthcare segment was EUR 28.5 million (8.5)
and operating profit was EUR 2.6 million (0.3) 
-- Turnover for the Clinics and Hospitals segment was EUR 16.6 million (12.0)
and operating profit was EUR 3.2 million (3.1) 
-- Turnover for the Diagnostics segment was EUR 6.8 million (7.7) and operating 
profit was EUR 4.1 million (1.3)                                                
-- Turnover for other, i.e. items not unallocated to the segments, was EUR 1.1 
million (1.0) and operating result was EUR -5.4 million (-2.1).                 
- Full year 2008 turnover and operating profit is expected to grow
significantly from 2007. 


Suomen Terveystalo Group's (Terveystalo) turnover increased in January-March    
2008 by 80.7 percent compared to the corresponding period in the previous year  
and amounted to EUR 52.9 million (EUR 29.3 million in January-March 2007).      
Operating profit grew by 71.2 percent and amounted to EUR 4.4 million (2.6).    

--------------------------------------------------------------------------------
| KEY FIGURES                |    1.1.- |      1.1.- |    Change, |      1.1.- |
|                            | 31.3.2008|  31.3.2007 |         %  | 31.12.2007 |
|                            |          |            |            |            |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Turnover, EUR 1,000        |   52,868 |     29,264 |      80.7% |    140,719 |
--------------------------------------------------------------------------------
| Operating profit, EUR      |    4,442 |      2,595 |      71.2% |        401 |
| 1,000                      |          |            |            |            |
--------------------------------------------------------------------------------
| Earnings per share, EUR    |     0.01 |       0.03 |     -66.7% |      -0.05 |
--------------------------------------------------------------------------------
| Equity per share, EUR      |     1.21 |       0.82 |      47.6% |       1.20 |
--------------------------------------------------------------------------------
| Net gearing, %             |    188.0 |      132.7 |      41.7% |      184.8 |
--------------------------------------------------------------------------------
| Return on investment, %    |     10.6 |       12.2 |     -13.1% |        0.6 |
--------------------------------------------------------------------------------
| Return on equity, %        |      5.4 |       14.1 |     -61.7% |       -5.0 |
--------------------------------------------------------------------------------
| Capital adequacy, %        |     28.0 |       31.7 |     -11.7% |       27.5 |
--------------------------------------------------------------------------------
| Operating profit /         |      8.4 |        8.9 |      -5.6% |        0.3 |
| turnover, %                |          |            |            |            |
--------------------------------------------------------------------------------


The income statement figures used to calculate ROI and ROE have been annualized.


SUOMEN TERVEYSTALO OYJ'S INTERIM REPORT                                         
1.1. - 31.3.2008                                                                

Business operations                                                             

Measured by turnover and the extent of its operations, Terveystalo is Finland's 
leading healthcare company. The company operates in private healthcare service  
markets and offers its customers comprehensive healthcare services.             

The Group's business operations are divided into three business segments: the   
Occupational Healthcare segment, the Clinics and Hospitals segment and the      
Diagnostics segment. Until the end of 2007 all imaging and laboratory services  
were reported as part of the Diagnostics segment. From the beginning of 2008,   
sample-taking laboratory operations and express analytics as well as imaging    
services are reported as part of the Clinics and Hospitals segment, in terms of 
clinic hospitals and clinics, and as part of the Occupational Healthcare segment
in terms of occupational clinics. Business operations not allocated to any      
particular segment are reported under the heading “Other”, which mainly consists
of the company's holding in the business operations of AVA clinics specializing 
in infertility treatments.                                                      

Business segment information for 1.1.-31.3.2007 and for the whole year 2007 is  
presented corresponding to the business segment division taken into use as of   
the beginning of 2008.                                                          

In the first quarter of 2008, Terveystalo continued integrating its services and
internal operating methods that was started in 2007. The aim of the integration 
that will continue until the end of 2008 is to clarify operating procedures,    
boost the efficiency of the unit network, reduce overlaps and simplify support  
and administration services so that they better correspond to the needs of the  
Group's extended business operations.                                           

Occupational Healthcare segment                                                 
As a result of the Medivire Työterveyspalvelut Oy acquisition carried out at the
beginning of September 2007, Terveystalo Group became the leading provider of   
occupational healthcare services in Finland, measured by both turnover and the  
extent of the network. At the end of 2007 the company was responsible for the   
healthcare services of more than 12,000 corporate customers and more than       
365,000 individuals.                                                            

In January, Suomen Terveystalo Oyj was granted an SFS-EN ISO 9001:2000 quality  
certificate. In the first quarter the company continued integrating the         
processes and operating models in occupational healthcare that began in late    
2007. The training package directed at occupational healthcare specialists was  
made part of the specialization and further training of occupational healthcare 
doctors offered by universities. Approximately 30 doctors with occupational     
healthcare specialist teaching rights operate across Finland within Terveystalo.


Clinics and Hospitals segment                                                   
In the first quarter of 2008 the company continued developing its clinic        
hospitals and clinics. The aim is that the clinic hospitals will support the    
service offering of smaller units and ensure the availability of Terveystalo's  
services regionally and nationally. A standardized and extensive service network
is expected to have a positive effect on Terveystalo's market position in the   
long term.                                                                      

A new clinic hospital was taken into use in Turku during March, where five      
previously separately-operating Terveystalo clinics moved into the same         
premises. In addition to a 1.5 Tesla magnet, a new 3.0 Tesla device was acquired
for the imaging unit of the new clinic hospital. The more powerful image signal 
and shorter imaging time improves image quality and thus both diagnostics and   
diagnosis reliability. In Joensuu, Terveystalo and the city of Joensuu started  
the first cooperation between a private and public healthcare provider in joint 
premises where part of the premises is used in the daytime by the public health 
center, and by Terveystalo in the evenings. The agreement, which also includes  
cooperation in terms of equipment and treatment products and, in the future,    
possibly also in terms of laboratory tests and sample taking, is an example of  
how a new way of thinking can result in cost-efficient and functional           
cooperation models between the public and private healthcare sectors.           

A majority of Terveystalo's sample-taking laboratories operate in units         
belonging to the Clinics and Hospitals segment as the company focuses on        
sample-taking laboratory operations and related services that happen in the     
customer interface.                                                             

The Diagnostics segment is responsible for X-ray and MRI imaging in the imaging 
units that belong to this segment and offers mobile imaging and screening       
services to external customers, as well as internally to complement the         
healthcare services offered to the customers of the Occupational Healthcare and 
Clinics and Hospitals segments. The Diagnostics segment also has Group-wide     
responsibility for developing diagnostics services and for ensuring that the    
diagnostics equipment used in the Group is up-to-date.                          

In January-March 2008, more than ten separate imaging units operated within the 
Terveystalo Group. A majority of imaging services are carried out in units      
belonging to the Clinics and Hospitals segment.                                 

Group functions support Group level, regional and local business operations. At 
the beginning of 2008, the Group's operational structure was strengthened by    
adding quality to Group functions which already included HR, sales, finance, ICT
and communications. Insurance services-related operations are also a            
responsibility at the Group level.                                              

Group structure                                                                 

In the review period, the Suomen Terveystalo Group consisted of the parent      
company Suomen Terveystalo Oyj and its 36 subsidiaries. No new subsidiaries or  
business operations were acquired in the review period.                         

Turnover                                                                        

In January-March 2008, turnover grew by 80.7 percent compared to the            
corresponding period last year and amounted to EUR 52.9 million (EUR 29.3       
million in January-March 2007). The Occupational Healthcare segment's share of  
turnover was 53.8 percent, the Clinics and Hospitals segment's share was 31.4   
percent and the Diagnostics segment's share was 12.8 percent.                   

Turnover by segment                                                             

--------------------------------------------------------------------------------
| Turnover by segment     |            |            |            |             |
--------------------------------------------------------------------------------
| EUR 1,000               |      1.1.- |      1.1.- |  Change, % |       1.1.- |
|                         |  31.3.2008 |  31.3.2007 |            |  31.12.2007 |
--------------------------------------------------------------------------------
| Occupational Healthcare |     31,801 |      9,290 |     242.3% |      63,808 |
| segment                 |            |            |            |             |
--------------------------------------------------------------------------------
| Clinics and Hospitals   |     18,306 |     13,529 |      35.3% |      54,897 |
| segment                 |            |            |            |             |
--------------------------------------------------------------------------------
| Diagnostics segment     |      7,646 |      8,201 |      -6.8% |      32,489 |
--------------------------------------------------------------------------------
| Other                   |      1,077 |      1,047 |       2.9% |       2,667 |
--------------------------------------------------------------------------------
| Group eliminations      |     -5,961 |     -2,803 |     112.7% |     -13,142 |
--------------------------------------------------------------------------------
| Group total             |     52,868 |     29,264 |      80.7% |     140,719 |
--------------------------------------------------------------------------------


In addition to Group functions, the ”Other” item contains the Group's share of  
the operations of the AVA clinic that focuses on fertilization treatment and is 
not included in the business segments.                                          

Earnings                                                                        

In January-March 2008 the operating profit was EUR 4.4 million, i.e. 8.4 percent
of turnover (EUR 2.6 million, i.e. 8.9% of turnover in January-March 2007). The 
operating profit grew by 71.2 percent from the corresponding period last year.  
Operating profit includes one-off item from sales gain of the central laboratory
operations amounting to EUR 2.1 million. Operating profit of the group excluding
one-off item from review period amounts to EUR 2.4 million which is equivalent  
to 7.8 % of turnover. Operating profit excluding one-off item has decreased by  
7,8 % from the corresponding period last year.                                  
                                                                                
The earnings belonging to the owners of the parent company was EUR 0.9 million, 
i.e., 1.7 percent of turnover (EUR 1.2 million, 4.2 %). Earnings per share      
calculated from earnings belonging to the owners of the parent company was EUR  
0.01 (EUR 0.03).                                                                

Operating profit by segment                                                     

--------------------------------------------------------------------------------
| Operating profit by     |            |            |            |             |
| segment                 |            |            |            |             |
--------------------------------------------------------------------------------
| EUR 1,000               |      1.1.- |      1.1.- |  Change, % |       1.1.- |
|                         |  31.3.2008 |  31.3.2007 |            |  31.12.2007 |
--------------------------------------------------------------------------------
| Occupational Healthcare |       -736 |       -402 |      83.1% |      -6,441 |
| segment                 |            |            |            |             |
--------------------------------------------------------------------------------
| Clinics and Hospitals   |      1,440 |      1,597 |      -9.8% |       4,229 |
| segment                 |            |            |            |             |
--------------------------------------------------------------------------------
| Diagnostics segment     |      3,185 |        744 |     328.1% |       1,676 |
--------------------------------------------------------------------------------
| Other                   |     -5,409 |     -2,146 |     152.1% |     -12,204 |
--------------------------------------------------------------------------------
| Group eliminations      |      5,961 |      2,802 |     112.7% |      13,142 |
--------------------------------------------------------------------------------
| Group total             |      4,442 |      2,595 |      71.2% |         401 |
--------------------------------------------------------------------------------


The operating profit of the Diagnostics segment includes EUR 2.1 million sales  
gain from selling the central laboratory operations.                            

Return on assets                                                                

Return on investments (ROI) in January-March 2008 was 10.6 percent (12.2% in    
January-March 2007). Return on equity (ROE) was 5.4 percent (14.1%).            

Structure                                                                       

In February 2008, Suomen Terveystalo Oyj sold its central laboratory operations 
to Medix Laboratoriopalvelut Oy. Terveystalo still estimates that the strategic 
partnership with Medix Laboratoriot Oy related to mass analytics and special    
sample research will produce savings of at least EUR 0.5 million for the company
annually. The laboratories that perform express analytics in clinic hospitals,  
clinics and occupational healthcare centers were not included in the deal.      

The business divestment improved Terveystalo's preconditions to develop its     
sample-taking laboratory operations and express analytics in the customer       
interface, as well as also offering related services as outsourcing services.   
The national office network offers possibilities; for instance, to offer        
screening-related sample-taking services to municipalities.                     

The sales gain from the central laboratory operations including sales costs was 
EUR 2.1 million.                                                                

Investments                                                                     

Terveystalo continued investing in imaging equipment and in updating and        
developing premises. In January-March 2008, for instance, the new clinic        
hospital in Turku that was opened in March and the new clinic hospital that was 
opened in Rovaniemi in April, as well as new or renewed premises in Forssa,     
Joensuu, Kemi and Kurikka, were furnished.                                      

Balance sheet and financing                                                     

At the end of March 2008 the balance sheet total was EUR 294.2 million (EUR     
124.1 million at the end of March 2007). Balance sheet total has increased      
significantly due to the acquisition of Medivire Työterveyspalvelut Oy on       
September 2007. Liquidity remained good in January-March 2008. The Group's      
liquid assets, including financial securities, amounted to EUR 6.2 million (5.9)
at the end of the period.                                                       

Net gearing was 188.0 percent (132.7 %) at the end of the first quarter.        

Cash flow                                                                       

In January-March 2008 operational cash flow was EUR 1.2 million (EUR 5.1 million
in January-March 2007). Interests paid have been presented on the cash flow from
financing instead of cash flow from operations and information from period      
January 1-March 31, 2007 and financial period 2007 have been changed            
correspondingly.                                                                

Cash flow from operations has decreased from the corresponding period last year 
due to increase in working capital. Increase in the Accounts receivable and     
other receivables has been higher that corresponding period last year.          

Personnel                                                                       

The average number of personnel in January-March 2008 was 2,390 (average in     
January March 2007 1,308 and 1,689 in 2007). The number of personnel at the end 
of March was 2,369 (1,335 at the end of March 2007 and 2,398 at the end of the  
fiscal period 2007). The increase in personnel resulted particularly from the   
acquisition of Medivire Työterveyspalvelut Oy in the fall of 2007.              

At the end of the period, approximately 2,100 professional independent          
entrepreneurs (practitioners) were receiving patients in the Group companies'   
premises.                                                                       

Based on a decision by the Board of Directors Suomen Terveystalo Oyj Group has  
launched a result and reward system for 2008 concerning all personnel.          

Organization                                                                    

In accordance with an integration plan approved on November 19, 2007 by Suomen  
Terveystalo Oyj's Board of Directors, operations in many towns have been or will
be partly or fully integrated into larger entities in order to increase         
efficiency and cost savings. During January-March 2008 units in, for instance,  
Hämeenlinna, Iisalmi, Kouvola, Pori, Rovaniemi, Savonlinna and Turku moved to   
new joint premises.                                                             

Shares and share capital                                                        

At the end of March, Suomen Terveystalo Oyj's share capital was EUR 681,416.63  
(EUR 681,416.63 at the end of 2007) and the total number of shares was          
68,141,663. The share ticker in the book-entry system is SUT1V.                 

During January-March 2008 the highest share price was EUR 1.99 and the lowest   
share price EUR 1.42. The medium share price weighted by the January-March share
exchange was EUR 1.66. The closing share price at the end of March was EUR 1.59.
During the review period a total of 5,141,345 shares were exchanged representing
7.6 per cent of the total amount of shares at the end of the review period. The 
market value of the share stock with the closing share price of 31 March, 2008  
was EUR 108,345,244. At the end of the review period the company had 6,672      
shareholders (6,510 at the end of 2007).                                        
                                                                                
Parent company Suomen Terveystalo Oyj does not own any company shares. The      
Group's subsidiaries Suomen Terveystalo Lääkäriasema Oy and Nova Clinic Oy own a
total of 55,691 parent company shares. This corresponds to 0.08 percent of the  
stock and votes.                                                                

The Board of Directors of Suomen Terveystalo Oyj resolved on February 21, 2008, 
by authorization of the Annual General Meeting on May 28, 2007, that stock      
options be issued to the key personnel of Suomen Terveystalo Oyj and its        
subsidiaries. In the same meeting, the Board approved the Group's result and    
reward system for 2008 concerning the entire personnel. The option rights are   
used to encourage the key personnel to sustained work in order to increase the  
owner value and to commit the key personnel to the employer. The total number of
option rights is 3,644,500 and they provide the right to subscribe for a maximum
of 3,644,500 of the company's new shares. The interest of the shares on the     
basis of the option rights is a maximum of 5.1 percent of the company's shares  
and voting rights associated with the shares after possible share subscriptions.
The share subscription price will be based on the prevailing market price of the
Suomen Terveystalo Oyj share on the OMX Nordic Exchange Helsinki in             
January—March 2008, 2009 and 2010. The share subscription price for 2008A stock 
options is, however, at least EUR 2.16 which corresponds to the share           
subscription price at which the personnel subscribed for shares in the initial  
public offering 2007. The share subscription period for 2008A stock options will
be January 2, 2011 — December 31, 2012; for 2008B stock options January 2, 2012 
— December 31, 2013, and for 2008C stock options January 2, 2013 — December 31, 
2014.                                                                           

Annual General Meeting 2008                                                     

Suomen Terveystalo Oyj's Annual General Meeting (AGM) was arranged in Helsinki  
on April 17, 2008. The Annual General Meeting approved the Board of Directors'  
proposal on the distribution of profits, according to which no dividend is paid 
and the loss of the fiscal year that ended on December 31, 2007 be transferred  
into the profit/loss account.                                                   

Board composition and compensation                                              

The number of Board members was confirmed by the AGM as eight (8). Managing     
Director Ari Ahola, Doctor Pentti Parkkinen, M.D., M.Pol.Sc. Kari Puro, M.Sc. in
Technology Kaija Pöysti, M.Sc., Harvard USA, University lecturer Pekka Roto and 
M.Sc. in Technology Petteri Walldén were re-elected as Board members, and DSc in
Economics Kari Neilimo and Director Matti Roto were elected as new Board        
members.                                                                        

The term of office of the Board will end at the conclusion of the next Annual   
General Meeting. A presentation of the Board members can be found on the        
company´s Internet pages at www.terveystalo.com.                                

The term of office compensation for the Chairman of the Board was set at EUR    
30,000, for the Deputy Chairman of the Board at EUR 21,600, and for the Board   
members at EUR 12,000, in addition to which the Chairman of the Board will      
receive a meeting compensation of EUR 800 and the Deputy Chairman of the Board  
and Board members will receive meeting compensation of EUR 600 for each Board or
Board committee meeting. Reasonable travel costs of Board members will be       
compensated against invoices.                                                   

In terms of auditors the Annual General Meeting decided that the current auditor
APA PricewaterhouseCoopers Oy, with APA Janne Rajalahti as the auditor in       
charge, will continue.                                                          

In the meeting held after the Annual General Meeting the Board of Directors     
re-elected Pentti Parkkinen as the Chairman of the Board and elected Kari       
Neilimo as the Deputy Chairman.                                                 

Events after the review period                                                  

On April 1, 2008 Jukka Yli-Hankala, M.Sc., was appointed as Suomen Terveystalo  
Oyj's CFO and member of the Group Management Team from June 1, 2008.            

Short-term risks and uncertainty factors                                        

Terveystalo takes controllable risks related to its strategy and objectives. The
risks are managed and minimized as far as possible, using a variety of means.   
The company is not prepared to take any risks that could endanger the continuity
of operations, or be uncontrollable or substantially impair its operations. The 
purpose of the company's risk management is to systematically and               
comprehensively identify risks associated with the operations, maintain         
risk-awareness and ensure that risks are managed appropriately in making of     
business decisions.                                                             

The most significant risks related to Terveystalo's operations include risks    
related to growth and acquisitions, social and legislative risks, risks related 
to malpractice cases and liability for damages, risks related to contracts,     
risks related to customer relationships, risks related to personnel and risks   
related to technology - including functionality of IT systems and information   
security. The aim is to manage these risks through operation guidelines and     
rules or to transfer them to another party through agreements and insurance     
policies.                                                                       

The main short-term risks include financial risks. In August 2007, the company  
increased its debt financing by EUR 134 million to finance the Medivire         
Työterveyspalvelut Oy acquisition. There are risks related to financing costs   
and loan repayments if the operational cash flow is low and/or interest rates   
rise considerably. The company manages its financing risks with an operational  
profitability program, interest rate hedging and continuous communication with  
the financers.                                                                  

Short-term risks also include risks related to the effects of the launch of new 
clinics and hospitals on the company's profitability in the short term if the   
implementation of operations in the new premises does not progress as planned.  
The biggest risks of this type are related to the operations that started in the
new clinic hospital in Turku in March and in Rovaniemi in April. Also the       
integration of Suomen Terveystalo Työterveys Oy (formerly Medivire              
Työterveyspalvelut Oy) and Terveystalo operations and systems can, if they are  
prolonged, have a significant effect on the benefits reaped from the integration
and on Group functions.                                                         

During the review period, the company continued its systematic risk management  
and development of internal supervision processes and systems in cooperation    
with an external audit partner, which was initiated in 2007.                    

Outlook                                                                         

According to published studies, private healthcare services are expected to grow
annually by an average of nine percent also in the coming years and the company 
will continue to strive for faster growth than the market on average. Growth in 
demand for occupational healthcare services is expected to continue. The general
growth outlook for private doctor services is regarded as good and the company  
expects the growth in the Clinics and Hospitals segment to continue. The sale of
the Diagnostics segment's services to the public sector, in particular, will    
continue growing, according to the company's projections.                       

Based on the general market growth, growth expectations in the organic business 
and implemented acquisitions, the company´s 2008 turnover is expected to clearly
exceed the 2007 turnover.                                                       

As part of the Group's integration program, the company initiated in late 2007 a
program to considerably improve operational efficiency and thus improve         
profitability. The company's operating profit for 2008 is expected to clearly   
exceed the 2007 operating profit.                                               

Financial reports 2008                                                          

In 2008, Suomen Terveystalo will publish the following interim reports:         
- interim report for January-June August 14, 2008 at approximately 1 p.m.
Helsinki time 
- interim report for January-September November 13, 2008 at approximately 1 p.m.
Helsinki time 



SUOMEN TERVEYSTALO GROUP                                                        

Suomen Terveystalo Oyj's interim report January 1 - March 31, 2008 has been     
compiled in accordance with the recognition and measurement principles set out  
in the International Financial Reporting Standards (IFRS), but not all of the   
requirements of IAS 34: Interim Financial Reporting has been followed. When     
compiling this interim report the company has applied the same principles as in 
the financial statement for the fiscal year that ended on December 31, 2007.    

The figures in the income statement and balance sheet are Group figures. All    
integral Group companies are consolidated in the Group's interim report. The    
interim report is unaudited.                                                    

--------------------------------------------------------------------------------
| CONSOLIDATED BALANCE SHEET, EUR 1,000     |                |                 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| ASSETS                    |     31.3.2008 |      31.3.2007 |      31.12.2007 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| LONG-TERM ASSETS          |               |                |                 |
--------------------------------------------------------------------------------
| Property, plant and       |        56,779 |         44,865 |          58,926 |
| equipment                 |               |                |                 |
--------------------------------------------------------------------------------
| Goodwill                  |       146,711 |         41,667 |         147,042 |
--------------------------------------------------------------------------------
| Other intangible assets   |        42,577 |          7,994 |          42,932 |
--------------------------------------------------------------------------------
| Investment property       |            45 |             47 |              45 |
--------------------------------------------------------------------------------
| Investments in associates |         1,384 |          1,560 |           1,262 |
--------------------------------------------------------------------------------
| Receivables from          |            17 |             17 |              17 |
| associates                |               |                |                 |
--------------------------------------------------------------------------------
| Financial assets          |         1,246 |          1,411 |           1,231 |
| available for sale        |               |                |                 |
--------------------------------------------------------------------------------
| Deferred tax receivables  |         4,897 |          2,166 |           4,924 |
--------------------------------------------------------------------------------
| TOTAL LONG-TERM ASSETS    |       253,657 |         99,727 |         256,381 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CURRENT ASSETS            |               |                |                 |
--------------------------------------------------------------------------------
| Inventories               |         2,049 |          1,645 |           2,102 |
--------------------------------------------------------------------------------
| Accounts receivable and   |        32,244 |         16,866 |          24,928 |
| other receivables         |               |                |                 |
--------------------------------------------------------------------------------
| Financial assets at fair  |          -313 |            387 |             397 |
| value through profit or   |               |                |                 |
| loss                      |               |                |                 |
--------------------------------------------------------------------------------
| Cash and cash equivalents |         6,536 |          5,502 |          13,088 |
--------------------------------------------------------------------------------
| TOTAL CURRENT ASSETS      |        40,516 |         24,400 |          40,516 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| TOTAL ASSETS              |       294,174 |        124,126 |         296,896 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| SHAREHOLDERS' EQUITY AND  |     31.3.2008 |      31.3.2007 |      31.12.2007 |
| LIABILITIES               |               |                |                 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| SHAREHOLDERS' EQUITY      |               |                |                 |
--------------------------------------------------------------------------------
| Share capital             |           681 |            472 |             681 |
--------------------------------------------------------------------------------
| Share issue               |             0 |            315 |               0 |
--------------------------------------------------------------------------------
| Share premium account     |           459 |         31,211 |             459 |
--------------------------------------------------------------------------------
| Unrestricted equity       |        77,809 |            100 |          77,809 |
| reserve                   |               |                |                 |
--------------------------------------------------------------------------------
| Retained earnings         |         1,798 |          5,238 |             889 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Minority interest         |         1,593 |          1,955 |           1,682 |
--------------------------------------------------------------------------------
| TOTAL SHAREHOLDERS'       |        82,340 |         39,291 |          81,520 |
| EQUITY                    |               |                |                 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| LONG-TERM LIABILITIES     |               |                |                 |
--------------------------------------------------------------------------------
| Deferred tax liabilities  |        12,029 |          3,574 |          12,492 |
--------------------------------------------------------------------------------
| Interest-bearing          |       138,669 |         44,105 |          21,292 |
| liabilities               |               |                |                 |
--------------------------------------------------------------------------------
| Other liabilities         |           458 |            415 |             459 |
--------------------------------------------------------------------------------
| TOTAL LONG-TERM           |       151,156 |         48,094 |          34,243 |
| LIABILITIES               |               |                |                 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CURRENT LIABILITIES       |               |                |                 |
--------------------------------------------------------------------------------
| Accounts payable and      |        37,111 |         23,199 |          38,462 |
| other liabilities         |               |                |                 |
--------------------------------------------------------------------------------
| Current tax liabilities   |            49 |            401 |             195 |
--------------------------------------------------------------------------------
| Current interest-bearing  |        23,516 |         13,141 |         142,476 |
| liabilities               |               |                |                 |
--------------------------------------------------------------------------------
| TOTAL CURRENT LIABILITIES |        60,676 |         36,741 |         181,133 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| TOTAL EQUITY AND          |       294,174 |        124,126 |         296,896 |
| LIABILITIES               |               |                |                 |
--------------------------------------------------------------------------------



--------------------------------------------------------------------------------
| CONSOLIDATED PROFIT AND LOSS |         1.1.- |         1.1.- |         1.1.- |
| ACCOUNT, EUR 1,000           |     31.3.2008 |     31.3.2007 |    31.12.2007 |
--------------------------------------------------------------------------------
| Turnover                     |        52,868 |        29,264 |       140,719 |
--------------------------------------------------------------------------------
| Other operating income       |         2,653 |           164 |         1,049 |
--------------------------------------------------------------------------------
| Share of profit of           |           122 |           189 |           365 |
| associates                   |               |               |               |
--------------------------------------------------------------------------------
| Raw material and consumables |        -7,262 |        -4,610 |       -23,955 |
| used                         |               |               |               |
--------------------------------------------------------------------------------
| Employee benefit costs       |       -25,497 |       -12,429 |       -63,476 |
--------------------------------------------------------------------------------
| Depreciation and impairment  |        -5,336 |        -2,459 |       -14,134 |
--------------------------------------------------------------------------------
| Other operating expenses     |       -13,107 |        -7,525 |       -40,166 |
--------------------------------------------------------------------------------
| OPERATING PROFIT             |         4,442 |         2,595 |           401 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Financial income             |            93 |            20 |           564 |
--------------------------------------------------------------------------------
| Financial expenses           |         4,022 |          -875 |        -5,092 |
--------------------------------------------------------------------------------
| PROFIT BEFORE TAXES          |           513 |         1,739 |        -4,126 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Income taxes                 |           307 |          -423 |         1,146 |
--------------------------------------------------------------------------------
| PROFIT FOR THE PERIOD        |           820 |         1,316 |        -2,980 |
--------------------------------------------------------------------------------
| Attributable to:             |               |               |               |
--------------------------------------------------------------------------------
| Parent group owners          |           909 |         1,218 |        -3,088 |
--------------------------------------------------------------------------------
| Minority interest            |           -89 |            98 |           107 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Earnings per share calculated on the earnings  belonging to the owners of    |
| the parent company (EUR)                                                     |
--------------------------------------------------------------------------------
| Undiluted                    |          0.01 |          0.03 |         -0.05 |
--------------------------------------------------------------------------------
| Diluted                      |          0.01 |          0.03 |         -0.05 |
--------------------------------------------------------------------------------
| CONDENSED CASH FLOW          |               |               |               |
| STATEMENT                    |               |               |               |
--------------------------------------------------------------------------------
| EUR 1,000                    |         1.1.- |          1.1.-|         1.1.- |
|                              |     31.3.2008 |     31.3.2007 |    31.12.2007 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Cash flow from operations    |               |               |               |
--------------------------------------------------------------------------------
| Profit for the period        |           820 |         1,316 |        -2,980 |
--------------------------------------------------------------------------------
| Adjustments to the profit    |         6,498 |         3,536 |        17,052 |
| for the period               |               |               |               |
--------------------------------------------------------------------------------
| Change in working capital    |        -6,366 |           748 |        -3,231 |
--------------------------------------------------------------------------------
| Interest received            |             6 |            16 |           514 |
--------------------------------------------------------------------------------
| Taxes paid                   |           253 |          -565 |        -1,870 |
--------------------------------------------------------------------------------
| Net cash flow from           |         1,212 |         5,051 |         9,485 |
| operations                   |               |               |               |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Cash flow from investments   |               |               |               |
--------------------------------------------------------------------------------
| Acquired operations          |             0 |          -592 |      -130,236 |
--------------------------------------------------------------------------------
| Investments in tangible and  |        -4,258 |         -3115 |       -15,455 |
| intangible assets            |               |               |               |
--------------------------------------------------------------------------------
| Disposal of associates       |             0 |             0 |           123 |
--------------------------------------------------------------------------------
| Gains on disposal of         |         3,399 |             0 |             0 |
| business operations          |               |               |               |
--------------------------------------------------------------------------------
| Gains on disposal of assets  |           361 |            31 |           335 |
--------------------------------------------------------------------------------
| Dividends received           |             1 |             2 |           465 |
--------------------------------------------------------------------------------
| Net cash flow from           |          -497 |        -3,674 |      -144,768 |
| investments                  |               |               |               |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Cash flow from financing     |               |               |               |
--------------------------------------------------------------------------------
| Share issue payments         |             0 |            18 |        48,187 |
--------------------------------------------------------------------------------
| Costs of issuing equity      |             0 |          -548 |        -2,065 |
--------------------------------------------------------------------------------
| Withdrawals of loans         |            12 |         1,397 |       134,829 |
--------------------------------------------------------------------------------
| Repayment of loans           |          -303 |        -1,762 |       -33,191 |
--------------------------------------------------------------------------------
| Interest paid                |        -5,901 |          -621 |        -2,327 |
--------------------------------------------------------------------------------
| Repayment of finance lease   |        -1,075 |          -929 |        -3,603 |
| liabilities                  |               |               |               |
--------------------------------------------------------------------------------
| Dividends paid               |             0 |            -2 |           -29 |
--------------------------------------------------------------------------------
| Net cash flow from financing |        -7,267 |        -2,447 |       141,800 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Liquid assets at beginning   |        13,088 |         6,571 |         6,571 |
| of period                    |               |               |               |
--------------------------------------------------------------------------------
| Liquid assets at end of      |         6,536 |         5,502 |        13,088 |
| period                       |               |               |               |
--------------------------------------------------------------------------------


--------------------------------------------------------------------------------
| CALCULATION OF CHANGES IN CONSOLIDATED SHAREHOLDERS' EQUITY 1.1. - 31.3.2008 |
--------------------------------------------------------------------------------
| EUR 1,000  | Share  | Share   | Share | Unre-    | Retai-  | Mino-  | Total  |
|            | capital| premium | issue | stric-   | ned     | rity   |        |
|            |        | account |       | ted      | earnings| inte-  |        |
|            |        |         |       | equity   |         | rest   |        |
|            |        |         |       | reserve  |         |        |        |
--------------------------------------------------------------------------------
| Sharehol-  |    681 |     459 |     0 |   77,809 |     889 |  1,682 | 81,520 |
| ders'      |        |         |       |          |         |        |        |
| equity     |        |         |       |          |         |        |        |
| Jan 1,2008 |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Profit for |      0 |       0 |     0 |        0 |     909 |    -89 |    820 |
| the period |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Shareholde-|    681 |     459 |     0 |   77,809 |   1,798 |  1,593 | 82,340 |
| rs' equity |        |         |       |          |         |        |        |
| March 31,  |        |         |       |          |         |        |        |
| 2008       |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| CALCULATION OF CHANGES IN CONSOLIDATED SHAREHOLDERS' EQUITY 1.1. - 31.3.2007 |
--------------------------------------------------------------------------------
| EUR 1,000  | Share  | Share   | Share | Unrestr- | Retained| Mino-  | Total  |
|            | capital| premium | issue | icted    | ear-    | rity   |        |
|            |        | account |       | equity   | nings   | inte-  |        |
|            |        |         |       | reserve  |         | rest   |        |
|            |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Shareholde-|    472 |  31,211 |   315 |      630 |   4,021 |  1,892 | 38,541 |
| rs' equity |        |         |       |          |         |        |        |
| Jan 1, 2007|        |         |       |          |         |        |        |
|            |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Costs of   |      0 |       0 |     0 |     -741 |       0 |      0 |   -741 |
| issuing    |        |         |       |          |         |        |        |
| equity     |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Deferred   |      0 |       0 |     0 |      193 |       0 |      0 |    193 |
| tax on     |        |         |       |          |         |        |        |
| costs of   |        |         |       |          |         |        |        |
| issuing    |        |         |       |          |         |        |        |
| equity     |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Rights     |      0 |       0 |     0 |       18 |       0 |      0 |     18 |
| issue      |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Dividend   |      0 |       0 |     0 |        0 |      -2 |      0 |     -2 |
--------------------------------------------------------------------------------
| Profit for |      0 |       0 |     0 |        0 |   1,218 |     98 |  1,316 |
| the period |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Minority   |      0 |       0 |     0 |        0 |       0 |    -35 |    -35 |
| interests  |        |         |       |          |         |        |        |
| in         |        |         |       |          |         |        |        |
| acquisiti- |        |         |       |          |         |        |        |
| ons and    |        |         |       |          |         |        |        |
| other      |        |         |       |          |         |        |        |
| changes    |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------
| Shareholde-|    472 |  31,211 |   315 |      100 |   5,237 |  1,955 | 39,290 |
| rs' equity |        |         |       |          |         |        |        |
| March 31,  |        |         |       |          |         |        |        |
| 2007       |        |         |       |          |         |        |        |
--------------------------------------------------------------------------------


--------------------------------------------------------------------------------
| SEGMENT REPORTING, 1,000 EUR  |         1.1- |         1.1.- |         1.1.- |
|                               |    31.3.2008 |     31.3.2007 |    31.12.2007 |
--------------------------------------------------------------------------------
| Turnover by segment           |              |               |               |
--------------------------------------------------------------------------------
| Occupational Healthcare       |       31,801 |         9,290 |        63,808 |
| Segment                       |              |               |               |
--------------------------------------------------------------------------------
| Clinics and Hospitals segment |       18,306 |        13,529 |        54,897 |
--------------------------------------------------------------------------------
| Diagnostics segment           |        7,646 |         8,201 |        32,489 |
--------------------------------------------------------------------------------
| Other                         |        1,077 |         1,047 |         2,667 |
--------------------------------------------------------------------------------
| Eliminations                  |       -5,961 |        -2,803 |       -13,142 |
--------------------------------------------------------------------------------
| Total turnover                |       52,868 |        29,264 |       140,719 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Operating profit by segment   |              |               |               |
--------------------------------------------------------------------------------
| Occupational Healthcare       |         -736 |          -402 |         -6441 |
| Segment                       |              |               |               |
--------------------------------------------------------------------------------
| Clinics and Hospitals segment |        1,440 |         1,597 |         4,229 |
--------------------------------------------------------------------------------
| Diagnostics segment           |        3,185 |           744 |         1,676 |
--------------------------------------------------------------------------------
| Other                         |       -5,409 |        -2,146 |       -12,204 |
--------------------------------------------------------------------------------
| Eliminations                  |        5,961 |         2,803 |        13,142 |
--------------------------------------------------------------------------------
| Total operating profit        |        4,442 |         2,595 |           401 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Financial income and expenses |       -3,929 |          -855 |        -4,528 |
--------------------------------------------------------------------------------
| Profit before tax             |          513 |         1,739 |        -4,126 |
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
| Taxes                         |          307 |          -423 |         1,146 |
--------------------------------------------------------------------------------
| PROFIT FOR THE PERIOD         |          820 |         1,316 |        -2,980 |
--------------------------------------------------------------------------------




--------------------------------------------------------------------------------
| CONSOLIDATED PROFIT AND LOSS ACCOUNT, BY QUARTER, EUR 1,000     |            |
--------------------------------------------------------------------------------
|               |      1.1- |    1.10.- |     1.7.- |        1.4- |      1.1.- |
|               | 31.3.2008 |31.12.2007 | 30.9.2007 |   30.6.2007 |  31.3.2007 |
|               |           |           |           |             |            |
--------------------------------------------------------------------------------
| Turnover      |    52,868 |    52,923 |    30,236 |      28,297 |     29,264 |
--------------------------------------------------------------------------------
| Other         |     2,653 |       321 |       164 |         399 |        164 |
| operating     |           |           |           |             |            |
| income        |           |           |           |             |            |
--------------------------------------------------------------------------------
| Share in      |       122 |       -50 |        83 |         143 |        189 |
| associated    |           |           |           |             |            |
| companies     |           |           |           |             |            |
| income        |           |           |           |             |            |
--------------------------------------------------------------------------------
| Raw material  |    -7,262 |    -9,780 |    -4,879 |      -4,686 |     -4,609 |
| and           |           |           |           |             |            |
| consumables   |           |           |           |             |            |
| used          |           |           |           |             |            |
--------------------------------------------------------------------------------
| Employee      |   -25,497 |   -24,271 |   -14,854 |     -12,396 |    -11,954 |
| benefit costs |           |           |           |             |            |
--------------------------------------------------------------------------------
| Depreciation  |    -5,336 |    -5,290 |    -3,707 |      -2,678 |     -2,459 |
--------------------------------------------------------------------------------
| Other         |   -13,107 |   -13,766 |    -9,579 |      -8,825 |     -8,000 |
| operating     |           |           |           |             |            |
| expenses      |           |           |           |             |            |
--------------------------------------------------------------------------------
| OPERATING     |     4,442 |        87 |    -2,536 |         254 |      2,595 |
| PROFIT        |           |           |           |             |            |
--------------------------------------------------------------------------------
| Financial     |        93 |       141 |       101 |         302 |         20 |
| income        |           |           |           |             |            |
--------------------------------------------------------------------------------
| Financial     |    -4,022 |    -2,771 |    -1,025 |        -421 |       -875 |
| expenses      |           |           |           |             |            |
--------------------------------------------------------------------------------
| Profit before |       513 |    -2,542 |    -3,459 |         135 |      1,739 |
| tax           |           |           |           |             |            |
--------------------------------------------------------------------------------
| Income taxes  |       307 |       680 |       938 |         -49 |       -423 |
--------------------------------------------------------------------------------
| PROFIT FOR    |       820 |    -1,862 |    -2,522 |          87 |      1,316 |
| THE PERIOD    |           |           |           |             |            |
--------------------------------------------------------------------------------
| Attributable  |           |           |           |             |            |
| to:           |           |           |           |             |            |
--------------------------------------------------------------------------------
| Parent        |       909 |    -1,810 |    -2,527 |          31 |      1,218 |
| company       |           |           |           |             |            |
| shareholders  |           |           |           |             |            |
--------------------------------------------------------------------------------
| Minority      |       -89 |       -52 |         5 |          56 |         98 |
| interest      |           |           |           |             |            |
--------------------------------------------------------------------------------


--------------------------------------------------------------------------------
| OTHER INFORMATION               |      1.1.- |       1.1.- |           1.1.- |
|                                 |  31.3.2008 |   31.3.2007 |       31.12.2007|
--------------------------------------------------------------------------------
| Average personnel               |      2,390 |       1,308 |           1,689 |
--------------------------------------------------------------------------------
| Personnel at end of period      |      2,369 |       1,335 |           2,398 |
--------------------------------------------------------------------------------


Calculation of financial ratios:                                                

Return on equity, %	=                                                           
100 x (Profit before tax - direct taxes)/                                       
(Shareholders' equity + minority interest (average))                            

Return on investment, % =                                                       
100x (Profit before tax + interest expenses + other financial expenses)/        
(Balance sheet total - non-interest-bearing liabilities (average))              

Capital adequacy, % =                                                           
100 x (shareholders' equity + minority interest) / (Balance sheet total -       
advances received)                                                              

Net gearing =                                                                   
(Interest-bearing liabilities - liquid assets) /                                
(Shareholders' equity + minority interest)                                      

Undiluted earnings per share =	                                                 
(Profit before tax - minority interest - income taxes) /                        
Weighted average number of outstanding shares                                   

Diluted earnings per share =                                                    
(Profit before tax - minority interest - income taxes) /	                       
Weighted average number of outstanding shares adjusted for dilution             

Equity per share =	                                                             
Shareholders' equity / 	                                                        
Undiluted number of share at end of fiscal period                               


SUOMEN TERVEYSTALO OYJ
Board of Directors


FOR ADDITIONAL INFORMATION, PLEASE CONTACT:                                     
Managing Director Martti Kiuru, tel. +358 30 63 311,                            
martti.kiuru@terveystalo.com                                                    


The bulletin and tables are available at: http://www.terveystalo.com            


Terveystalo:                                                                    
Suomen Terveystalo is the leading company producing healthcare services in      
Finland. The company offers healthcare, occupational healthcare and hospital    
services to private individuals, companies and the public sector through more   
than 150 offices across Finland. The company, which was founded in 2001, has    
grown strongly. The company share is listed on the OMX Nordic Exchange Helsinki 
under the code SUT1V.                                                           

The statements about the future are based on the situation when the bulletin was
published and the actual outcome may differ from the statements. Anything in    
this bulletin that is not historical fact is a statement about the future.      
Statements about the future contain known and unknown risks, uncertainties and  
other factors that may lead to considerable deviation in Suomen Terveystalo     
Group's actual earnings, operations and accomplishments compared to any         
statements related to future earnings, operations and accomplishments included  
in such a statement on the future. Such factors include general economic and    
operating environment-related conditions, additions and changes to the          
competitive situation, the company's ability to implement and utilize its       
investment program, the success of the unification program for operations       
initiated in September 2007 and the company's ability to continue expanding its 
operations.                                                                     


Distribution:                                                                   
OMX Nordic Exchange Helsinki                                                    
Principal media